Philips Reports Significant Net Income Growth in Second Quarter Fueled by Tariff Refunds and Regional Performance Divergence
Royal Philips has reported a substantial surge in net income for the second quarter of 2026, a result largely driven…
Health Technology & Apps
Laila Zulfa Boston Scientific Initiates Major 2024 Global Restructuring Program to Optimize Operations and Support Strategic Growth Initiatives
Boston Scientific, a preeminent leader in the global medical technology sector, has officially announced the commencement of a comprehensive multi-year…
Aidoc Secures FDA Breakthrough Designation for Generative AI Diagnostic Tool First Read to Automate Chest X-ray Reporting and Clinical Workflows
The United States Food and Drug Administration (FDA) has officially granted a breakthrough device designation to Aidoc, a leading provider…
FDA Approves Freenome SimpleScreen Blood-Based Colorectal Cancer Test and Triggers One Hundred Million Dollar Milestone Payment from Abbott
The U.S. Food and Drug Administration has granted formal approval to Freenome’s SimpleScreen, a non-invasive blood-based screening test designed to…
FDA Identifies Class I Recall of Boston Scientific Enroute Transcarotid Neuroprotection System Following Risks of Device Component Failure
The U.S. Food and Drug Administration (FDA) has categorized the recent recall of the Enroute Transcarotid Neuroprotection System (NPS), manufactured…
Edwards Lifesciences Reports Strong Second Quarter Performance and Raises Annual Sales Outlook Amid Robust Demand for Structural Heart Therapies
Edwards Lifesciences, a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring, reported second-quarter financial…
GE HealthCare CFO Jay Saccaro steps down
GE HealthCare Technologies Inc. has officially announced a significant shift in its executive leadership team alongside the release of preliminary…
Leadership Void at the FDA: Industry Stability Threatened by Prolonged Search for Permanent Commissioner
The United States Food and Drug Administration (FDA) is currently navigating a period of significant administrative transition that has left…
Vicarious Surgical to Dissolve and Liquidate Assets Following Shareholder Approval
The era of Vicarious Surgical as a high-profile contender in the robotic-assisted surgery market has officially come to an end…
FDA Selects Dexcom as Inaugural Participant in TEMPO Pilot Program to Accelerate Digital Health Innovation and Real-World Evidence Collection
In a landmark move for the medical technology sector, the U.S. Food and Drug Administration (FDA) has officially designated Dexcom…
